Microparticles for drug delivery across mucosa and the blood-brain barrier

Inactive Publication Date: 2002-07-16
GASCO
View PDF8 Cites 49 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

An important problem in the field of the administration and the absorption of drugs consists of the difficulty of the passage for some drugs through the intestinal mucosa and of the difficulty of the passage through the blood-brain barrier and the blood-cerebrospinal fluid barrier.
In fact the drugs administered by mouth and destined to pass through the intestinal mucosa find a limitation due to the gastrointestinal pH, to the residence time and to the solubility.
For example biodegradable drugs such as proteins and peptides, and slight

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 2

A mixture consisting of 273.6 mg of water, 16.4 mg of phosphatidylcholine, 20.0 mg of butanol, 32.0 mg of sodium taurocholate, 2.4 mg of butyric acid and 2.8 mg of dipalmitoyl phosphatidyl ethanolamine-PEG (steric stabilizer), warmed at 70.degree. C., is added under stirring to 52.0 mg of the water / oil microemulsion of the step b) of the Example 1.

The preparation is completed according to the steps d) and e) of the Example 1.

The following results are obtained:

drug incorporated in the microparticles: 78%;

average diameter of the microparticles: 100 nm;

polydispersion index: 0.24.

example 3

a) A mixture consisting of 24 mg of stearic acid and 6.0 mg of monostearine is warmed at 70.degree. C.;

b) a mixture consisting of 6.0 mg of gentamicin, 56.0 mg of sodium taurocholate, 28.0 mg of soy-bean phosphatidylcholine and 280.0 mg of water, warmed at 70.degree. C., is added under stirring to the mixture of the step a) obtaining an oil in water microemulsion.

The microemulsion obtained in the step b) is then treated as described in the steps d) and e) of the Example 1.

The following results are obtained:

gentamicin incorporated in the microparticles: 80%;

average diameter of the microparticles: 105 nm;

polydispersion index: 0.22.

example 4

a) A mixture consisting of 210.0 mg of stearic acid, 10.0 mg of monostearine, 62.0 mg of soy-bean phosphatidylcholine, 80.0 mg of butyric acid and 6.0 mg of butanol is warmed at 70.degree. C.

b) 36.0 mg of an aqueous solution of calcitonin (2 mg / ml) warmed at 68.degree. C. are added to the mixture of the step a) obtaining a water / oil microemulsion.

c) A mixture consisting of 214.4 mg of water, 16.8 mg of soy-bean phosphatidylcholine, 16.4 g of butyric acid, 8.0 g of butanol and 32.4 g of sodium taurocholate, warmed at 70.degree. C., is added under stirring to 52.0 mg of the water / oil microemulsion of the step b), obtaining a water / oil / water microemulsion.

The preparation is then completed working according to the steps d) and e) of the Example 1.

The following results are obtained:

incorporation of the calcitonin: 83%;

average diameter of the microparticles: 93 nm;

polydispersion index: 0.23.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Percent by massaaaaaaaaaa
Percent by massaaaaaaaaaa
Login to view more

Abstract

Pharmaceutical composition comprising micro particles having an average diameter ranging from 40 to 150 nm, consisting of one or more lipids, a drug and, optionally, a steric stabilizer, suitable to the transmucosal passage and to the overcoming of the blood-brain barrier and the blood-cerebrospinal fluid barrier, said micro particles being obtained dispersing in an aqueous medium cooled to 2-4° C. an oil/water or a water/oil/water micro emulsion comprising said constituents.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner GASCO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products